Views on GlaxoSmithKline Pharmaceuticals Limited 4QFY2016 Results: Angel Broking

Views of Ms. Sarabjit Kour Nangra (VP Research - Pharma , Angel Broking) on GlaxoSmithKline Pharmaceuticals Limited 4QFY2016 Results:

Glaxo Pharmaceuticals (CMP: INR 3425 / TP: / Upside:)

"For 4QFY2016 Glaxo Pharma posted sales of INR 686cr, a YoY growth of 11.8%. On operating front, the gross margins came in at 55.0% V/s 57.1% during the last corresponding period, while EBDITA came in at 17.8% V/s 19.4% during the last corresponding period. The reported net profit thus came in at INR 106cr V/s INR 103cr during the last corresponding period a YoY growth of 2.9%. The Adj. net profit thus came in at INR 95cr V/s INR 107cr during the last corresponding period. We remain NEUTRAL on the stock."

Shares of GLAXOSMITHKLINE PHARMACEUTICALS LTD. was last trading in BSE at Rs.3525 as compared to the previous close of Rs. 3515.55. The total number of shares traded during the day was 325 in over 112 trades.

The stock hit an intraday high of Rs. 3532 and intraday low of 3484. The net turnover during the day was Rs. 1141110.

Source : Equity Bulls

Keywords